Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study
The COVID-19 pandemic had no impact on the overall use of antithrombotic agents. However, a short-term increase in antiplatelet initiation and long-term changes in warfarin, dabigatran, and factor Xa initiations were observed after the COVID-19 outbreak.
Authors
- Björn Wettermark (ORCID: https://orcid.org/0000-0003-0531-2516)
- H Li
- Mohammadhossein Hajiebrahimi (ORCID: https://orcid.org/0000-0001-8118-4988)
- Maria Palmetun‐Ekbäck
- Salar Mousa
Institutions
- Uppsala University (SE)
- Örebro University (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Basic & Clinical Pharmacology & Toxicology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1111/bcpt.70213
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Svenska Forskningsrådet Formas
- Hjärt-Lungfonden
- Norges Forskningsråd